BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24903759)

  • 1. Factors Affecting Seroconversion Rates in Cattle Vaccinated with Two Commercial Inactivated BTV-8 Vaccines Under Field Conditions.
    Vitale N; Radaelli MC; Chiavacci L; Paoletti M; Teodori L; Savini G
    Transbound Emerg Dis; 2016 Apr; 63(2):175-83. PubMed ID: 24903759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A one-year follow-up of antibody response in cattle and sheep after vaccination with serotype 8- and serotype 1-inactivated BT vaccines.
    Zanella G; Bréard E; Sailleau C; Zientara S; Viarouge C; Durand B
    Transbound Emerg Dis; 2014 Oct; 61(5):473-6. PubMed ID: 23331382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep.
    Oura CA; Wood JL; Sanders AJ; Bin-Tarif A; Henstock M; Edwards L; Floyd T; Simmons H; Batten CA
    Vaccine; 2009 Dec; 27(52):7326-30. PubMed ID: 19786141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colostral antibody induced interference of inactivated bluetongue serotype-8 vaccines in calves.
    Vitour D; Guillotin J; Sailleau C; Viarouge C; Desprat A; Wolff F; Belbis G; Durand B; Bakkali-Kassimi L; Breard E; Zientara S; Zanella G
    Vet Res; 2011 Feb; 42(1):18. PubMed ID: 21314901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the humoral response between sheep vaccinated with a killed-virus vaccine and those vaccinated with a modified-live virus vaccine against bluetongue virus serotype 17.
    Speiser KL; Schumaker BA; Cook WE; Cornish TE; Cammack KM; Miller MM
    J Am Vet Med Assoc; 2016 May; 248(9):1043-9. PubMed ID: 27074613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
    Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V
    Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two year BTV-8 vaccination follow up: molecular diagnostics and assessment of humoral and cellular immune reactions.
    Hund A; Gollnick N; Sauter-Louis C; Neubauer-Juric A; Lahm H; Büttner M
    Vet Microbiol; 2012 Jan; 154(3-4):247-56. PubMed ID: 21840139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines.
    Bartram DJ; Heasman L; Batten CA; Oura CA; Plana-Durán J; Yuen HM; Wylie AD
    Vet J; 2011 May; 188(2):193-6. PubMed ID: 20466568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of Antibodies against Bluetongue Virus (BTV) in Sheep 5 to 7.5 Years after Vaccination with Inactivated BTV-8 Vaccines.
    Hilke J; Strobel H; Woelke S; Stoeter M; Voigt K; Moeller B; Bastian M; Ganter M
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31181733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral response to 2 inactivated bluetongue virus serotype-8 vaccines in South American camelids.
    Zanolari P; Bruckner L; Fricker R; Kaufmann C; Mudry M; Griot C; Meylan M
    J Vet Intern Med; 2010; 24(4):956-9. PubMed ID: 20492489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response in cattle vaccinated against bluetongue serotype 8 in Italy.
    Calistri P; Giovannini A; Savini G; Bonfanti L; Cordioli P; Lelli R; Caporale V
    Transbound Emerg Dis; 2010 Jun; 57(3):180-4. PubMed ID: 20569419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle.
    Anderson J; Hägglund S; Bréard E; Comtet L; Lövgren Bengtsson K; Pringle J; Zientara S; Valarcher JF
    Clin Vaccine Immunol; 2013 Aug; 20(8):1115-22. PubMed ID: 23720365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BTV antibody longevity in cattle five to eight years post BTV-8 vaccination.
    Ries C; Beer M; Hoffmann B
    Vaccine; 2019 May; 37(20):2656-2660. PubMed ID: 30979569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy.
    Savini G; Ronchi GF; Leone A; Ciarelli A; Migliaccio P; Franchi P; Mercante MT; Pini A
    Vet Microbiol; 2007 Sep; 124(1-2):140-6. PubMed ID: 17499459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
    Anderson J; Hägglund S; Bréard E; Riou M; Zohari S; Comtet L; Olofson AS; Gélineau R; Martin G; Elvander M; Blomqvist G; Zientara S; Valarcher JF
    Vaccine; 2014 Nov; 32(49):6614-21. PubMed ID: 25312275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence after vaccination of cattle and sheep against Bluetongue Virus (BTV) serotype 8 in Sweden.
    Hultén C; Frössling J; Chenais E; Sternberg Lewerin S
    Transbound Emerg Dis; 2013 Oct; 60(5):438-47. PubMed ID: 22889362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DIVA system based on the detection of antibodies to non-structural protein 3 (NS3) of bluetongue virus.
    Barros SC; Cruz B; Luís TM; Ramos F; Fagulha T; Duarte M; Henriques M; Fevereiro M
    Vet Microbiol; 2009 Jun; 137(3-4):252-9. PubMed ID: 19233575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats.
    Bréard E; Belbis G; Hamers C; Moulin V; Lilin T; Moreau F; Millemann Y; Montange C; Sailleau C; Durand B; Desprat A; Viarouge C; Hoffmann B; de Smit H; Goutebroze S; Hudelet P; Zientara S
    Vaccine; 2011 Mar; 29(13):2495-502. PubMed ID: 21256877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.